Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study

Background: The excess risk of bilateral visual impairment (BVI; bilateral visual acuity <0.5) among individuals with amblyopia is an argument for screening for amblyopia, but data are scarce. Methods: The risk was estimated by determining the incidence of BVI in the Rotterdam Study, a population-based cohort of subjects aged 55 years or over (n  =  5220), including 192 individuals with amblyopia (3.7%). Using a multistate lifetable, the lifetime risk and excess period spent with BVI were determined. Results: The relative risk of BVI for amblyopes was 2.6 (95% confidence interval 1.4–4.5). For individuals with amblyopia, the lifetime risk of BVI was 18%, whereas they lived on average 7.2 years with BVI. For non-amblyopic individuals, these figures were 10% and 6.7 years, respectively. Conclusion: Amblyopia nearly doubles the lifetime risk of BVI and affected individuals spent an extra six months with BVI. This study provides data for future cost-effectiveness analyses.

[1]  P. Mitchell,et al.  Consequences of amblyopia on education, occupation, and long term vision loss , 2004, British Journal of Ophthalmology.

[2]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[3]  S. Logan,et al.  Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study , 2002, The Lancet.

[4]  R. Klein,et al.  Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study. , 2001, Ophthalmology.

[5]  A Hofman,et al.  Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.

[6]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[7]  D L Sackett,et al.  An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.

[8]  E. Podell,et al.  Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. , 1988, The New England journal of medicine.

[9]  A. Tarkkanen,et al.  Incidence of loss of vision in the healthy eye in amblyopia. , 1981, The British journal of ophthalmology.

[10]  R. Cumming,et al.  Prevalence and causes of amblyopia in an adult population. , 1998, Ophthalmology.

[11]  R. Klein,et al.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.